The Kowledge Transfer Network (KTN) has published the “Microbiome Strategic Roadmap” .
Microbiome diagnostics could be employed to improve disease diagnostics, quantify disease risk, predict disease severity and progression, and tailor drug-choice to individual patients. Check the updates in the field of Microbiome in relation with the OA.
